- €499.32m
- €491.57m
- €788.37m
Brief: Evotec 9M Revenue EUR 535.1 Million
Brief: BRIEF TEMPLATE
Brief: Evotec Receives $25 Mln Payment From Bristol Myers Squibb To Support Joint Programs
Brief: STOXX Ltd. Announces September 2025 Review Results Of DAX Indices
Brief: Evotec H1 Revenue At EUR 371.2 Mln
Evotec agrees sale of France plant to Sandoz, shares rise
Brief: Sandoz Signs Non-Binding Term Sheet To Buy Just-Evotec Biologics In Toulouse
Brief: Evotec SE And Sandoz AG Planning Potential Sale Of Evotec Biologics Toulouse Site
Brief: Evotec Cuts FY Revenue Guidance
Brief: Evotec Says Joins Nurture-Aki Consortium To Gain Multi-Omics-Based Molecular Understanding Of Acute Kidney Injury
Brief: Evotec Receives $2.5 Mln Grant For Tb Treatments
Evotec drops after Q1 miss
Brief: Evotec Outlook FY Revenue EUR 840-880 Million
Brief: Evotec Announces Progress In Protein Degradation Collaboration With Bristol Myers Squibb
Europe Research Roundup: Baloise Holding, Moncler, Syncona
Evotec rises on new midterm outlook and strategy overhaul
Brief: Evotec Outlook FY Revenue Eur 840-880 Mln
Brief: Evotec Says Black Creek Investment Management Inc. Holds 3.13% Of Total Voting Rights And Instruments
Brief: Evotec Announces Key Progress In Neuroscience Collaboration With Bristol Myers Squibb